[1] |
TALLMAN M S. Treatment of relapsed or refractory acute promyelocytic leukemia[J]. Best Pract Res Clin Haematol, 2007, 20(1):57-65.
DOI
URL
|
[2] |
SOIGNET S L. Clinical experience of arsenic trioxide in relapsed acute promyelocytic leukemia[J]. Oncologist, 2001, 6(Suppl 2):11-16.
DOI
URL
|
[3] |
ZHOU J, ZHANG Y, LI J, et al. Single-agent arsenic trioxide in the treatment of children with newly diagnosed acute promyelocytic leukemia[J]. Blood, 2010, 115(9):1697-1702.
DOI
PMID
|
[4] |
MATHEWS V, GEORGE B, CHENDAMARAI E, et al. Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia:long-term follow-up data[J]. J Clin Oncol, 2010, 28(24):3866-3871.
DOI
URL
|
[5] |
GHAVAMZADEH A, ALIMOGHADDAM K, ROSTAMI S, et al. Phase Ⅱ study of single-agent arsenic trioxide for the front-line therapy of acute promyelocytic leukemia[J]. J Clin Oncol, 2011, 29(20):2753-2757.
DOI
URL
|
[6] |
中华医学会血液学分会, 中国医师协会血液科医师分会. 中国急性早幼粒细胞白学病诊疗指南(2014年版)[J]. 中华血液学杂志, 2014, 35(5):475-477.
|
[7] |
DESANGLES F, VILAIN E, ARBORIO M, et al. t(15;17) hypergranular acute promyelocytic leukemia(M3) developing into a t(3;6) M3 without t(15;17) at relapse[J]. Leuk Lymphoma, 1995, 19(1-2):185-188.
DOI
URL
|
[8] |
饶若, 姚红霞, 金丽华, 等. 1例t(15;17)的急性早幼粒细胞白血病复发后核型演变成ins(17;15)的病例报道并文献复习[J]. 临床血液学杂志, 2016, 29(1):55-56.
|
[9] |
任维肖, 陈秀花, 任颜, 等. 急性早幼粒细胞白血病治疗后继发急性髓系白血病部分分化型一例并文献复习[J]. 白血病·淋巴瘤, 2020, 29(9):556-560.
|
[10] |
DE BOTTON S, SANZ M A, CHEVRET S, et al. Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy[J]. Leukemia, 2006, 20(1):35-41.
DOI
PMID
|
[11] |
AGUNAS-RANGEL F A, CHÁVEZ-VALENCIA V. FLT3-ITD and its current role in acute myeloid leukaemia[J]. Med Oncol, 2017, 34(6):114.
DOI
URL
|
[12] |
张之南, 郝玉书, 赵永强, 等. 血液病学[M]. 2版. 北京: 人民卫生出版社, 2011.
|